|
GENOVAC pioneered the development of genetic immunization
and has an unmet track record of more than 800 projects. Over
eight years we have established a series of immunization plasmids
and strategies allowing us to choose the best possible strategy
to meet the demands of our clients and to ensure highest quality
of our products.
We offer basic (low budget) and optimized
strategies: For basic approaches (polyclonal)
you provide the expression plasmids (inclusive leader), whereas
for optimized projects (polyclonal and/or monoclonal)
we choose a strategy and use our IP-protected immunization
plasmids. The optimized strategy is applicable
to any protein.
In order to assess which optimized
strategy will apply for your antigen, please fill out our
free
questionnaire.
Other immunization techniques:
|
